Announced Mon, 22 Jun · 16:58 IST
Independent Director retires after completing first term
Management Changes View source PDF
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+10.2%1-day move
₹168.19
prior close
₹175.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9+0.9+0.9+0.9+10.2+15.8+21.5+27.6+34.0+28.7+29.1+44.5——
Up moveDown movePending
AI summary
Mr. Navin Kumar, an Independent Director of Bafna Pharmaceuticals, will retire upon completing his first term. The retirement takes effect from close of business hours on June 22, 2026. This is a routine end-of-tenure change and does not involve any governance concerns.
Likely market impact
Neutral. Routine completion of a director's tenure; no operational impact expected.